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SUMMARY
The mode of presentation of renal disease in 44 patients with essential mixed
cryoglobulinaemia (EMC) was: acute renal failure (two patients), acute nephritic
syndrome (six patients), nephrotic syndrome (eight patients), proteinuria and/or
haematuria (28 patients). Renal biopsy, performed in 35 patients, showed proliferative
lesions in 33, while only minimal glomerular changes were seen in the remaining two.
Immunofluorescence studies showed: IgG (85 per cent), IgA (36 per cent), IgM (90 per
cent), C3 (90 per cent), Clq (47 per cent), and C4 (33 per cent) deposits, mainly located in
subendothelial position. On electron microscopy, crystalloid structure of deposits and
monocy te infiltration of capillary loops were the outstanding feature. The survival rate was
75 per cent at 10 years from the onset of clinical symptoms. Thirty-nine patients were
followed for three to 146 months (mean 53-8). Twelve patients died, cardiovascular disease
and infection being the commonest cause of death. Thirteen patients showed acute renal
failure or acute nephritic syndrome: nine recovered completely, whereas the remaining
four died during the acute renal episode. Three patients developed chronic renal failure, but
only one required chronic dialysis. The ominous significance of renal impairment in EMC
should therefore be revaluated. The high prevalence of hypertension (28/44 patients) which
was refractory to treatment in six, may be important to the clinical outcome.
INTRODUCTION
Wintrobe and Buell (1933) first defined cryoglobulins as cold precipitating or geling
plasma proteins. Although several plasma proteins have been found in the
cryoprecipitate (Putnam, 1960; Ritzmann, Levin, and Galvestone, 1961; Varriale,
Ginsberg, and Sass, 1962; Allen, 1966; Alper, 1966; Lewis, Van Ommen, and
Page, 1966; Hanauer and Christian, 1967; Liss, Fudenberg, and Kritzman, 1967;
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Grupe, 1968; Zinneman, Levi, and Seal, 1968; Cuprak, Stollar, Kritzraan, and
Liss, 1970), immunoglobulins (Igs) are the proteins more frequently detected so
that the term of'cryoimmunoglobulinaemia' has been proposed (Grey and Kohler,
1973). Immunochemical analysis of cryo-Igs identified three distinct groups: Type
I are characterized by the presence of isolated monoclonal Igs or Bence-Jones
proteins. In Type II mixed cryo-Igs with monoclonal component possessing
antibody activity against polyclonal Igs can be detected. Type III is characterized
by a mixture of polyclonal Igs composed of one or more heavy chain classes. The
presence of cryo-Igs has been described in multiple myeloma and Waldenstrom's
macroglobulinaemia (Meltzer and Franklin, 1966; Barnett, Bluestone, Cracchiolo,
Goldberg, Kantor, and Mclntosh, 1970; Bonomo, Dammacco, Tursi, and Trizio,
1970), in other haematopoietic malignancies (Alexanian, 1975), in tropical
splenomegaly (Fakunle, Onyewotu, Greenwood, Mohammed, and Holborow,
1978), in acute and chronic infections (Mullinax, James, Mullinax, and Himrod,
1966; Mustakallio, Lassus, Putkonen, and Wager, 1967; Kaplan and Parker,
1966; Wager, Rasanen, Hagman, and Klenola, 1968; Kantor, Goldberg,
Johnson, Derechin, and Barnett, 1970; Bonomo and Dammacco, 1971; Kaufman
and Mclntosh, 1971; Hurwitz, Quismorio, and Friou, 1975), in autoimmune
diseases (Christian, Hatfield, and Chase, 1963; Block, Buchanan, Wohl, and
Bunin, 1965; Mustakallio, Lassus, and Wager, 1967; Talal, Zisman, and Schur,
1968; Statsny and Ziff, 1969; Weisraan and Zvaifler, 1976; McPhaul, 1978), in
human acute and chronic glomerulonephritis (Mclntosh, Kaufman, Kulvinskas,
and Grossman, 1970; Adam, Morel-Maroger, and Richet, 1973; Drouet,
Leutounturier, Contet, and Mandet, 1973; Conte, Blanc, Mignon-Conte, Abbal,
and Orfila, 1974; Mclntosh, Griswold, Chernack, Williams, Strauss, Kaufman,
Koss, Mclntosh, Cohen, and Weil, 1975), in experimental glomerulonephritis
(Griswold and Brady, 1978), in acute and chronic liver disease (Florin-Christensen,
Roux, and Arana, 1974; Mclntosh, Koss, and Gocke, 1975; Jori, Buonanno,
D'Onofrio, Tirelli, Gonnella, and Gentile, 1977), and in renal allotransplantation
(Andrejak, Bariety, Bedrossian, Callard, Duret, Duboust, Idatte, and Kuhn, 1978).
Cryoimmunoglobulinaemia has also been reported without evidence of any
underlying disease. In 1966, Meltzer, Franklin, Elias, McCluskey, and Cooper
described mixed essential cryoimmunoglobulinaemia, a syndrome consisting of
purpura, arthralgia, and a high prevalence of renal damage. However the
description of cryoglobulinaemic nephropathy is generally based upon individual
cases and follow-up data are very sparse.
In this paper 44 patients with essential mixed cryoglobulinaemia (EMC) and
nephropathy are reported. Consideration is given to (a) the clinical and biological
symptoms, (b) light-, electron- and immunofluorescence microscopy findings, and
(c) long-term evolution and pathogenetic mechanisms responsible for renal
damage.
METHODS
The methods used for the detection of serum cryoglobulins, complement
component concentrations and rheumatoid factor activity have been described
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previously (Tarantino, Anelli, Costantino, De Vecchi, Monti, and Massaro, 1978).
HBS antigen (Ag) was measured in whole serum kept in 37 °C by radio-
immunoassay using commercially available Abbott kits.
A, G, and M immunoglobulin concentrations in whole serum were determined
by radial immunodifFusion utilizing commercially available immunoplates
(Behring). C3 and C3PA (Proactivator) breakdown products were measured by
immunofixation and/or crossed immunoelectrophoresis (Tarantino et ai, 1978).
Renal histology
Percutaneous renal biopsies were performed in the majority of patients. Three
(micrometre) sections of Dubosq-Brazil-fixed tissue were stained with haematoxylin
and eosin, periodic acid Schiff, Masson's thrichrome and silver methenamine for
light microscopy. The slides were evaluated independently by two observers
without previous knowledge of clinical and laboratory data.
Glomerular lesions were semiquantitatively scored for the following items:
intracapillary proliferation, epithelial proliferation, polymorphonuclear cells,
mononuclear cells, increase of mesangial matrix, 'double contour' appearance of
glomerular basement membranes, subendothelial deposits, intraluminal thrombi,
glomerular scarring. Tubular and vascular lesions were scored for tubular
vacuolization, tubular atrophy, interstitial infiltration, interstitial fibrosis, vessel
sclerosis, and vasculitis. Each item was rated negative (—) and + to + + +.
Immunofluorescence
Immunohistological studies with fluorescein isothiocyanate labelled antisera to
human IgA, IgG, IgM, C3, Clq, and fibrinogen were performed on 4 /urn frozen
sections of renal specimens. Staining for IgD, IgE, and C4 was obtained by indirect
immunofluorescence method.
Electron microscopy
Renal biopsy fragments (1 mm3) and 15 in-vitro cryoprecipitates were fixed in 3
per cent glutaraldehyde and embedded in epon. Ultrathin sections—which were
stained with uranyl acetate and lead citrate—were examined with a Philips EM 200
(Zollinger and Mihatsch, 1978). At least two glomeruli were studied, and tubules,
interstitial tissue and vessels if available. The glomerular lesions were semi-
quantitatively scored as described under light microscopy for the following items:
cells in glomerular capillaries (polymorphonuclear leukocytes, lymphocytes,
monocytes, monocytes with droplets), osmiophilic deposits with and without
crystalloid structure, glomerular and vascular thrombi as well as further
parameters mentioned under light microscopy.
Patients
Criteria for inclusion in this study were: (a) longstanding hystory of purpura and
arthralgia, (b) absence of myelomatosis, Waldenstrom's macroglobulinaemia or
patent infection, (c) presence of more than 80 //g/ml of cryoprecipitate, and (d)
rheumatoid factor activity. Clinical history was carefully taken to establish the
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onset of symptoms. The beginning of the period of observation was considered as
the time of the first admission.
Definition and classification of renal manifestations
Proteinuria: protein excretion exceeding 0-2 g/24 hours.
Haematuria was classified as follows: - (0 to 3 RBC/HPF), + (4 to 10
RBC/HPF), + + (11 to 20 RBC/HPF), + + + (>20 RBC/HPF).
Nephrotic syndrome: proteinuria greater than 3 g/24 hours, serum albumin
concentration lower than 3 g/dl, and oedema.
Acute nephritic syndrome: a combination of haematuria and proteinuria with
a sudden rise of serum creatinine up to 600 /miol/1.
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Acute renal failure: a rapid increase of serum creatinine to levels higher than
800 //mol/1 with or without a reduction of urinary output.
Hypertension: diastolic blood pressure persistently greater than 95 mm.Hg.
Statistical studies
Students' / and corrected chi-square test were used. The results were considered
statistically significant only when/? was at least <0-01.
RESULTS
(a) Initial Data
Among the 44 patients included, 17 were males and 27 females. The mean
age was 47-2 ± 11-5 years (range 21-80). The main presenting features are shown
in Table 1. Purpura, arthralgia and hepatomegaly were the commonest manifest-
ation (50 per cent of patients), whereas weakness, fever and splenomegaly were
observed less frequently. Necrotizing skin lesions occurred in two patients (Cases
1 and 2), abdominal pain in two (Cases 4 and 12) and Raynaud's phenomenon
in three (Cases 29, 40 and 41). Liver damage was found in seven (Cases 13 to 16,
35, 42 and 43), in six liver biopsy was performed showing cirrhosis (Cases 35 and
43), chronic active hepatitis (Case 14) and chronic persistent hepatitis (Cases 13,
16 and 42). The remaining patient had abnormally high levels of serum trans-
aminases at repeated determinations.
In whole serum HB viral antigen showed a 7 per cent incident (two out of 28
patients).
(b) Renal abnormalities at the time of diagnosis
The onset of renal manifestations was coincident to the extrarenal signs in 13
patients (29 per cent). In the others the delay between the onset of systemic and
renal symptoms ranged from 2 to 447 months (mean 77 months). Clinical and
biochemical features of renal disease at the time of diagnosis are summarized in
Table 2. Acute renal failure was the presenting syndrome in two patients (4-5
per cent) (Cases 1 and 39); nephrotic syndrome in eight (18 per cent) (Cases 3,
7, 12, 13, 17, 29, 42 and 44); acute nephritic syndrome in six (13-5 per cent)
(Cases 8,10, 25, 27, 32 and 34); isolated proteinuria in six (13-5 per cent) (Cases
5, 9, 19, 24, 31 and 40) and isolated microscopic haematuria in 10 (23 per cent)
(Cases 14 to 16, 30, 33, 36 to 38, 41 and 43). In 12 patients (27-3 per cent)
renal abnormalities consisted of microscopic haematuria and proteinuria (Cases 2,
4, 6, 11, 18, 20 to 23, 26, 28 and 35). Hypertension was present in 22 patients
(50 per cent) (Cases 1 to 4, 6 to 10,18, 20, 22, 25, 28, 29, 31, 34, 36, 37, 39, 41
and 44).
(c) Serum complement levels
Serum samples (243) from 30 patients were assessed for Clq, Cls, C4, C3,
C5, C9, C3PA, Cl INH (Inhibitor) as well as whole serum complement activity
(Table 3). Early complement components (Clq, Cls and C4) and CH50 were
strongly depressed, while C3 did not differ from normal values; later components
(C5 and C9), C3PA and C l INH were higher than normal controls. In 18 patients
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T A B L E 3. Serum complement component and immunoglobulin levels in normal
subjects and patients with essential mixed cryoglobulinaemia
Component Normal controls Patients
No. of Mean ± S.D. No. of Mean ± S.D.
samples samples
CH50
Clq
Cls
C4
C3
C5
C9
C3PA
46
47
42
48
48
44
46
48
43-52+ 16-36
98-23 + 16-65
99-29 + 22-13
103-24 + 34-40
99-33 ±26-69
97-14 + 23-45
104-57 + 39-82
95-38 + 20-96
243
243
160
243
243
134
151
243
20-62 + 18-85
53-08 + 39-44
63-34 + 36-95
43-04 + 67-57
92-69 + 42-85
116-44 ±31-13
127-86 + 93-16
110-47 + 49-08
8-51
12-90
8 0 0
9 1 3
1-40
-4-34
-2-43
-3-49
< 0-001
< 0-001
< 0-001
< 0-001
N.S.
< 0-001
<002
< 0-001
C1INH 30 101-45 ±16-83 71 145-43 ± 33-72 -8-72 < 0-001
IgA
IgG
IgM
43
43
43
190-
1453-
167-
16
37
34
+ 98-18
+ 226-15
+ 57-80
213
213
211
143-54
1143-24
231-28
+ 83-
+ 591
+ 173
17
•76
•44
2
5
- 4
•91 «
•85 <
•30 <
CO
CO
CO
•005
•001
•001
serial measurements of complement components were performed for a period
ranging from six to 55 months; 13 out of them (72 per cent) had persistently low
C4 and/or Clq concentrations while fluctuation of C3 levels occurred. Five
patients with normal values at the time of first determination showed only slight
changes from baseline values for all components during the follow-up study.
Fifty-two EDTA plasma samples from 26 patients were checked at different times
but circulating C3 and C3PA breakdown products were never found.
(d) Immunoglobulin levels
Thirty patients (213 serum samples) were tested for immunoglobulin concentra-
tions (Table 3). A significant decrease of serum IgA and IgG was observed, while
IgM levels were significantly higher than in normal controls.
(e) Pathology: light microscopy
Renal biopsy was performed in 35 patients (47 biopsies), but in two (Cases 6
and 20) one tissue specimen was unavailable for light microscopy. Morphological
findings of 45 biopsies are semiquantitatively reported in Table 4. Three biopsies
from two patients (Cases 30 and 41) showed normal renal histology. Mesangial
proliferative glomerulonephritis was observed in 15 biopsies from 13 patients.
In 27 out of 45 biopsies (22 patients) a membranoproliferative glomerulonephritis
was present (Fig. 1). Thirty biopsies showed a cell accumulation in glomerular
capillary loops. In 12 out of 30 biopsies mononuclear cells were the only or pre-
dominant in glomerular capillaries. Sometimes these cells were filled by large pro-
tein droplets and occluded capillary lumina (Fig. 2). In 16 biopsies hyaline thrombi
were found in the glomeruli (Figs. 1 and 2), in four patients (Cases 1,5,32 and 34)
the thrombi were very extensive and occluded most of the glomerular capillaries.
Crescents were present in six biopsies (Cases 1, 10, 11, 17, 25 and 29), but they
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FIG. 1. Case No. 9. Membranoproliferative glomerulonephritis with marked increase of
mesangial matrix. Fibrinoid thrombi occluding some loops. (Masson thrichrome x 320.)
FIG. 2. Case No. 8. Part of a glomerulus showing massive hyaline thrombi in capillary
lumen (*). In other loops the lumina are occluded by mononuclear cells filled by hyaline
droplets of variable size ( ^ ) . (Azure methylene blue stain x930.)
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were focal and segmental. Tubular necrosis was found in four patients (Cases 1,
17, 32 and 34). Interstitial inflammation was observed in 24 biopsies; in two
patients (Cases 22 and 29) lymphoid follicles were present.
Vasculitis with fibrinoid necrosis of the wall and infiltration of polymorpho-
nuclear and mononuclear cells involved focally the small arteries, arterioles and less
frequently interlobular arteries in eight patients (Cases 8, 10, 11, 23, 28, 29, 38
and 44) (Fig. 3). A marked intimal fibrosis of interlobular arteries was observed in
ten patients (Cases 11,17, 22, 23, 25,27,38, 40, 41, and 44).
Serial biopsies
Ten out of 35 patients had repeated kidney biopsies, and 12 such biopsies
were performed 10 to 50 months after the initial one. Two serial biopsies were
carried out in eight patients (Cases 1,6,9, 20, 27, 29, 30 and 40), and three in two
patients (Cases 5 and 22). In Cases 6 and 20 renal tissue was not available for
histology in the first biopsy. Six patients showed identical morphologic pictures
in successive biopsies. In Case 1, membranoproliferative glomerulonephritis in
the first biopsy changed to mesangial proliferative glomerulonephritis in the
second; and vice versa in Case 5.
An increase in tubular atrophy, interstitial fibrosis and glomerular obsolescence
was found in four patients (Cases 22,27,29 and 40).
Immunofluorescence studies
Thirty-three renal biopsies from 29 patients were examined by immuno-
fluoresence. Diffuse granular deposits of immunoglobulins and complement
Fio. 3. Case No. 11. Severe necrotizing artheritis involving a small artery. Part of a
glomerulus showing typical lesions of membranoproliferative type. (PAS x32O.)
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FIG. 4. Immunofluorescence studies of case No. 6. Diffuse granular deposits irregularly
distributed on peripheral capillary walls. (Anti-IgM serum x32O.)
T A B L E 5. Semiquantitative evaluation of renal biopsy at immunofluorescence
No. M D Clq C4 C3 Fibrin Thrombi Vessels
1 II
3
4
5 D
6 I
II
8
10
12
13
17
19
20 I
II
21
22
23
24
25
26
27
28
29 I
II
30 I
II
31
32
34
38
41
42
44
Total
A, G,M
M,C3
A, G, M
G,M
G,M
A,G,M,Clq
1 
1 
1 
1 
1 
1
G, M
A, G, M, D, E
G.M.Clq
M
G,C3
M,C3
G
M.Clq
M
G,M
M
G
G,M
G
M
A,G,M,C3
85% 36% 90% 33% 29% 47% 33% 90% 24%
G,M,C4,Clq M,C3,Clq
—, No deposits; =, Not performed.
12 A. Tarantino and others
FIG. 5. Immunofluorescence study of case No. 32. Large thrombi in many capillary
lumina and scanty deposits along glomerular basement membranes. (Anti-IgM serum x280.)
were found in all but four biopsies (Table 5). IgG, IgM and C3 were found in
about 90 per cent of cases, the other immunoglobulins and complement com-
ponents in 29 to 47 per cent of cases. Clq and/or C4 deposits were found in
11 out of 22 biopsies in which these components were simultaneously assessed.
Deposits were mainly localized along the glomerular basement membranes (Fig. 4).
In two biopsies (Cases 30 and 41) the deposits were only in the mesangial region.
Fluorescence from immuneglobulin was generally more intense than complement
(Figs. 5 and 6). In 10 biopsies intraluminal thrombi were the most characteristic
FIG. 6. Immunofluorescence study of the same case illustrated in Fig. 5. Complement
deposits are present only on peripheral capillary loops. (Anti-Clq serum x28O.)
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T A B L E 6. Electron microscopy findings
Patient Hmotogic*! Polymorpho- Lymphocytes Mooocytej Mooocytes SubendotheEal
No. pattern aucteir mkb targe crysulkcd
teococyta droplet*
Deposits
with
Mesanfk! latraJiumm]
crysuSoid
3
8
9
10
13
17
32
37
41
MP
MP +
MP
MP +
MP +
MP +
MP +
mp +
N
MP - MerobnnoprohTerarive GN, mp - Mesangia] profifenlive GN. N - Norm*] gloraerub or
structure, t In flomenilar loopj or mterstitU] vessels.
* Obsolescent loops, t With crysulkxd
feature and again the staining with immunoglobulins always predominant.
Complement component staining was slight if present at all. Four different patterns
of deposit distribution were recognized: (1) Intraluminal thrombi, alone or in
association with scanty parietal deposits. (2) Peripheral subendothelial deposits.
(3) Mesangial deposits only. (4) No deposits.
In 14 specimens granular deposits were present in the arterioles or small arteries
walls. In nine instances immunoglobulins only were detected, in the remaining
FIG. 7. Glomerular capillary loop with massive subendothelial deposits exhibiting a
crystalloid structure (D) and part of a hyaline thrombus (T). E = erythrocytes, P =
podocytes with fusion or foot processes. (EM x 12100.)
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specimens C3 was seen four times and Clq two times as well. Fine granular
deposits of immunoglobulins were observed rarely in the interstitial tissue.
Electron microscopy
Ten kidney specimens obtained from 10 patients were examined (Table 6). In
one patient, showing minimal glomerular lesions at light microscopy, an increase of
mesangial matrix with electron dense mesangial deposits was observed. In the other
patients in addition to the glomerular abnormalities evaluated by light microscopy,
the following ultrastructural characteristics were identified: (1) A variable amount
of crystalloid deposits was located in subendothelial position with or without
mesangial interposition (Fig. 7). (2) The crystalloid deposits were often surrounded
by areas of amorphous, weakly osmiophilic and translucent material, attributed
to deposit degradation (Fig. 8). (3) Circulating aggregates of crystalloid material
were found in two cases in glomerular and peritubular capillaries (Fig. 9) and
arterioles. (4) Hyaline (protein) thrombi, e.g. giant crystalloid aggregates, occluded
capillary lumina (Fig. 7). (5) The crystalloid material consisted of straight or
slightly curved pairs of cylinders with a faint cross striation. In cross section they
appeared as annular bodies (Fig. 10a). In vitro cryprecipitates showed an identical
structure (Fig. 10b). (6) Non-crystalloid deposits were found in subendothelial
FIG. 8. Glomerular capillary loop with a large subendothelial deposit The strongly
osmiophilic parts of the deposit ( ^ ) exhibit a crystalloid structure, the more translucent
central parts (*) are amorphous (sign of a deposit dissolution?). Defect (<=>) in Bowman's
capsule basement membrane (CBM). P = podocyte, CE = capsular epithelium, BM =
basement membrane. (EM x 13800.)
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position in all cases, and in the mesangium on three occasions. (7) Monocytes,
polymorphonuclear leucocytes and in some cases lymphocytes were present in
variable number in glomerular capillaries. They were often found in close contact
to crystalloid deposits, and seemed sometimes to be engaged in deposit phago-
cytosis and degradation (Figs. 11 and 12). (8) Monocytes containing highly
osmiophilic, proteic droplets were present in most cases. These proteic droplets
never showed a crystalloid structure (Fig. 12). (9) Virus particles were never seen
in glomerular deposits or in the in vitro precipitates.
(/) Follow-up data
Three patients {Cases 33, 35 and 36) were lost to follow-up. The clinical course
of 41 patients is summarized in Fig. 13. Two patients {Cases 32 and 34) died
within one month after admission during an episode of acute nephritic syndrome.
Thirty-nine patients were followed for a period ranging from three to 146 months
(mean 53-8). Total follow-up time was 2099 months. Ten patients showed a
complete and prolonged remission {Cases 15,16, 22, 23, 25, 29 to 31, 38 and 41).
At the time of diagnosis isolated haematuria or proteinuria was present in six out
of 10 patients, while the presenting symptoms were proteinuria and haematuria in
two other patients, nephrotic or acute nephritic syndrome in two patients. One of
these patients {Case 29) died of cerebral haemorrhage 97 months after the onset of
extrarenal symptoms.
FIG. 9. Peritubular capillary with a large circulating aggregate with crystalloid structure
(*). Scanty subendothelial deposits (••). L = lymphocyte. (EM x 7600.)
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FIG. 10. Crystalloid structure of deposit in the glomemlus (a) and identical structure in the
in vitro cryoprecipitate (b) of the same patient. The deposits consist of straight or slightly
curved paired cylinders (<=» (up to 1 fim long) and annular structures (H)- Between the
cylinders a faint cross striation can be discerned. P = podocyte, BM = basement membrane.
(EM x 13500.)
In 16 other patients {Cases 2, 3, 6, 9, 11, 13, 14, 18, 19, 21, 24, 28, 37, 40, 43
and 44) renal function remained normal despite the persistence of urinary symp-
toms. Three patients {Cases 11, 14 and 19) in this group died of cerebral hae-
morrhage, sepsis and cachexia after 84, 75, and 51 months respectively. The
remaining 13 patients experienced several clinical manifestations including acute
renal failure (four episodes), acute nephritic syndrome (seven episodes), and
nephrotic syndrome (seven episodes), sometimes followed by periods of complete
remission. Three of them developed chronic renal failure and died of heart failure
{Cases 12 and 39) or hyperkalaemia {Case 27), 72, 120, 134 months after the
onset of extrarenal symptoms, and 72, 30 and 128 months after the onset of renal
manifestations. Patient 27 was the only one who was treated by chronic haemo-
dialysis. Three other patients {Cases 17, 26 and 42) died of myocardial infarction,
acute B hepatitis, and sepsis (Table 7). The duration of EMC was 156, 88 and 56
months. The remaining seven patients {Cases 1,4, 5, 7, 8,10 and 20) had normal
renal function with persistence of urinary abnormalities.
In summary, 19 cumulative episodes of acute renal failure or nephritic syndrome
were observed in 14 patients. Four patients {Cases 17, 32, 34 and 42) died during
acute renal disease, but the cause of death was not strictly related to renal failure.
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FIG. 11. Glomerular capillary loop with numerous subendothelial deposits (D). A poly-
morphonuclear leukocyte (PL) lying immediately upon the basement membrane and an
activated endothelial (?) cell (E) are possibly engaged in deposit phagocytosis ( ^ ) and
degradation. P = podocyte with fusion of foot processes, BM = basement membrane,
E = activated endothelial (?) cell. (EM x97OO.)
In the remainder, normal renal function was achieved. Twenty-two patients
showed an increase in blood pressure at the time of diagnosis. During follow-up
six other patients (Cases 12, 14, 26, 27, 40 and 42) became hypertensive. All
the hypertensive patients required vigorous antihypertensive therapy; in six
patients (Cases 3, 4, 6, 12, 26 and 39) poor control was achieved despite
adequate therapy.
The actuarial survival rate of 44 patients calculated from the onset of symptoms
was 93 and 75 per cent at five and 10 years respectively (Fig. 14). No significant
relationship could be detected between mortality rate and some clinical and
T A B L E 7. Causes of death
Sepsis
Cerebral haemorrhage
Heart failure
Myocardial infarction
Acute HbsAg + hepatitis
Hyperkalaemia
Cachexia
Total
4 (Patients no. 14, 32, 34, 42)
2 (Patients no. 11, 29)
2 (Patients no. 12,39)
1 (Patient no. 17)
1 (Patient no. 26)
1 (Patient no. 27)
1 (Patient no. 19)
12 out of 44 patients (28%)
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r
FIG. 12. The glomerular capillary loops are occluded by monocytes (M) stuffed with
osmiophilic (protein) droplets. Numerous subendothelial deposits ( ^ ) are in immediate
contact with the monocytes. CBM = capsular basement membrane. (EM x37OO).
morphological parameters such as mode of presentation, hypertension, intra-
luminal thrombi, membranoproliferative glomerulonephritis, mononuclear cell
infiltration.
(g) Treatment
In many patients treatment varied widely during the course of the syndrome.
Table 8 shows the initial treatment. Three patients (Cases 15, 18 and 31) were
T A B L E 8. Long-term effect of different immunosuppressive schedules in essential
mixed cryoglobulinaemia
(a)
(*)
to(d)
to
Total
No. ofpatiemi
3(15,18,31)
9(14, 16, 19,23,
32,39,41,43,44)
3(11,21,40)
11(17,20,22,24,
25, 27-30, 34, 37)
15(1-10, 12, 13,
26, 38, 42)
41
Treatment
Untreated
Oral corticoiteroidi
alone
Cytotoxic agents
Oral corticosteroids phu
cytotoxic agents
Oral corticosteroids plus
cytotoxic agents and
Lv. MRf pulses
Improved
1(15)
3(16,23,44)
—
5 (20, 22, 25,
28,30)
8(1 ,2 ,4 ,5 ,7 ,
8, 10, 38)
17
Unchanged
2(18,31)
2(41,43)
2(21,40)
2 (24, 37)
4(3 ,6 ,9 , 13)
12
Death, with or without
chronic renal failure
_
4(14, 19,32,39')
1(11)
4(17, 27*, 29, 34)
3(12*, 26,42)
12
* Chronic renal failure.
f Intravenous methylprednisolone.
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FIG. 13. Clinical course of renal disease during the follow-up in 39 patients.
20 A. Tarantino and others
100
90
<70
j
D
_i40
30
10
42 42 40
•v[7 2P^A i
V 1816V
1 \ JO 7 \
o FROM THE ONSET OF
SYMPTOMS
. FROM THE TIME OF
DIAGNOSIS
1 5 6 7 i
YEARS
HT 15 20 25
FIG. 14. Actuarial survival rates from the onset of symptoms and from the diagnosis of
EMC. The bars indicate the standard error on the estimated survival, calculated according
to Peto, Pike, Armitage, Breslow, Cox, Howard, Mantel, McPherson, Peto, and Smith
(1977). The number of patients still being followed at each point are indicated below
and above the survival curves respectively.
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FIG. 15. Clinical course in patient No. 10, treated by different drugs including intravenous
methylprednisolone pulses.
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never treated; nine patients {Cases 14,16,19, 23, 32, 39, 41, 43 and 44) received
low doses of oral prednisone only; in three patients {Cases 11, 21 and 40)
immunosuppressive drugs, azathioprine or cyclophosphamide, were used; a
combination of oral prednisone (0-5-1 mg/kg/day) and immunosuppressive
agents was given to 11 patients {Cases 17, 20, 22, 24, 25, 27 to 30, 34 and 37).
Fifteen patients {Cases 1 to 10,12, 13, 26, 38 and 42) were given in addition to
oral prednisone and immunosuppressants, three intravenous doses of 1 g methyl-
prednisolone at the beginning of treatment, repeated in most cases. Eleven patients
{Cases 1, 2, 4 to 8, 10, 12, 13 and 42) also received dipyridamole and heparin.
Four patients underwent plasmapheresis {Cases 1,6,13 and 26). The results with
intravenous high dose methylprednisolone have been impressive; the most
interesting finding being the dramatic improvement in the extrarenal signs such
as fever, purpura, arthralgia and abdominal pain, within 24 hours of administration.
Figure 15 illustrates the clinical course in one patient {Case 10) treated with
intravenous methylprednisolone.
DISCUSSION
(a) Clinical features
The mode of presentation described here, purpura, arthralgia, and weakness,
is typical of EMC and similar to those of other series (Jori and Buonanno, 1972;
Levo, Gorevic, Kassab, Tobias, and Franklin, 1977). There was a slight pre-
ponderance of females, and the onset of symptoms generally occurred in the third
or fourth decade of life. There is evidence that EMC is closely related to
Waldenstrom's macroglobulinaemia and other haematopoietic malignancies
(Invernizzi, Pioltelli, Cattaneo, Gavazzeni, Borzini, Monti, and Zanussi, 1979).
Repeat bone marrow examinations did not show any underlying lymphopro-
liferative disease in any of our patients, except one, who developed Waldenstrom's
macroglobulinaemia three years after the diagnosis of EMC.
Kidney involvement is frequent in EMC and may lead to a wide spectrum of
manifestations such as: renal tubular acidosis (LoSpalluto, Dorward, Miller, and
Ziff, 1962), nephrotic syndrome (Porush, Grishman, Alter, Mandelbaum, and
Churg, 1969; Bengtsson, Larsson, Lindstedt, and Svalander, 1975; Zimmerman,
Dreher, Burkholder, Goldfarb, and Weinstein, 1976), acute renal failure (Feizi
and Gitlin, 1969; Golde and Epstein, 1968; Lapes and Davies, 1970; Martinez
and Kohler, 1971), acute nephritic syndrome (Cordonnier, Vialtel, Martin,
Renversez, Chenais, Micouin, and Stoebner, 1977), papillary necrosis (Koelz
and Bourke, 1977), and minimal urinary abnormalities only (Klein, Van Rood,
Van Furth, and Radema, 1968). In our series the presentation of renal disease
was rather heterogeneous. Most of the patients had haematuria and/or proteinuria,
eight patients presented with the nephrotic syndrome, six patients with acute
nephritis, and two with acute renal failure. In eight out of 44 patients plasma
creatinine was above 150 //mol/1 at the first examination. Even if arterial hyper-
tension is a frequent finding in EMC, surprisingly this has not been noted in
previous reports. In this series 22 patients had diastolic hypertension on admission
and six others became hypertensive during the follow-up period.
22 A. Tarantino and others
(b) Aetiology
The aetiology of EMC is unknown. A specific antibody activity against parasitic,
bacterial, mycotic, and viral agents has been occasionally found in individual cases
(Williams and Kunkel, 1972; Kaplan and Parker, 1966; Wager, Mustakallio, and
Rasanen, 1968; Bonomo and Dammacco, 1971; Kaufman and Mclntosh, 1971;
Gamble and Ruggles, 1978). Moreover the demonstration of antibodies against
denatured or native DNA and the absence of rheumatoid factor activity in some
patients suggested that both IgG and IgM could be antibodies directed against
unknown antigens (Bluestone, Goldberg, Cracchiolo, and Barnett, 1970; Roberts
and Lewis, 1978).
Recently, the high incidence of HBs viral antigen as well as HBs antibodies
both in the serum and cryoprecipitate of patients affected by EMC was emphasized
(Levo, Gorevic, Kassab, Zucher-Franklin, and Franklin, 1977; Bombardieri,
Paoletti, Ferri, Di Munno, Fornai, and Giuntini, 1979). HBsAg particles were
also found by electron microscopy in four cryoprecipitates. These data would
imply that HBsAg is an aetiological factor of EMC. However several other
authors never detected HBsAg in patient sera (Zlotnick, Slavin, and Eliamkim,
1972; Bartlow, Oyama, Jng, Miller, Economou, Rennie, and Lewis, 1975; Cream,
1976; Zimmerman et al., 1976; Cordonnier et al., 1977; Koelz and Bourke, 1977).
In 14 renal biopsies, studied by immunofluorescence technique, we found
strong staining for anti-HBsAg serum in six cases. However this staining was
completely abolished by previous blocking of rheumatoid activity in tissue
specimens and no staining was achieved by anti-HBsAg (Fab)2 serum (Maggiore,
L'Abbate, Bartolomei, Caccamo, Barbiano di Belgiojoso, Tarantino, and
Colasanti, to be published). These results indicate that the staining with HBsAg
antiserum was related to the presence of rheumatoid factor bound in renal tissue,
therefore the search for antigens in tissue must include rheumatoid activity
blocking. Furthermore, virus particles were found neither in the glomerular
deposits, nor in in vitro cryoprecipitates, using electron microscopy.
Finally the reports mentioned above do not take into account the possibility that
the patients might have been transfused. One of our two patients with HBsAg
in serum had received many blood transfusions, and the other one died from acute
B hepatitis, after repeated plasmapheresis. Therefore HBsAg may be regarded as
a consequence rather than a cause of EMC.
(c) Renal pathology
The light microscopy features were those of a diffuse proliferation of glomeruli
in all but three renal specimens; it was surprising that the commonest lesion was
a typical picture of membranoproliferative glomerulonephritis (22 out of 35
patients). The majority of renal specimens from EMC patients, reported in the
literature, show glomerular changes compatible with this histological pattern
(Skrifvars, Tallqvist, and Tornroth, 1973; Morel-Maroger and Mery, 1974;
Zlotnick and Rosenmann, 1975; Cordonnier et al., 1977). Other morphological
features such as fibrinoid thrombi, the crystalloid structure of deposits, monocytic
infiltration and necrotizing vasculitis deserve more detailed discussion.
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Fibrinoid or hyaline thrombi in gloraerular capillary loops have been previously
considered as a characteristic finding of EMC nephritis (Verroust, Mery, Morel-
Maroger, Clauvel, and Richet, 1971; Zimmerman et ah, 1976; Zlotnick and
Rosenmann, 1975). Generally their presence paralleled more severe renal
impairment Our studies showed that fibrinoid thrombi found in one third of
biopsies, contained mostly immuneglobulins, while complement components were
less often present and fibrin was absent. In contrast to classic immune complex
disease, glomerular deposits of EMC nephropathy had a predominantly crystalloid
or fibrillar ultrastructure that may be considered as a unique finding (Cordonnier,
Martin, Grosslambert, Micouin, Chenais, and Stoebner, 1975; Feiner and Gallo,
1977; Ogihara, Saruta, Saito, Abe, Ozawa, Kato, and Sakuguchi, 1979). In our
cases, deposits with the crystalloid structure were mainly localized in sub-
endothelial sites and rarely in the mesangium as well as free in the lumina of
glomerular capillary loops, peritubular capillaries, and arterioles. This material is
composed of straight or curved cylinders and annular structures in cross sections.
We were unable to detect intracellular crystals or crystalloid material previously
described in glomerular cells of a few cases of EMC or monoclonal paraprotein-
aemia with nephritis (Porush et ai, 1969; Bengtsson et al., 1975; Monga,
Mazzucco, Coppo, Piccoli, and Coda, 1976).
It is also noteworthy that in vitro cryoprecipitates and immunoglobulins
present in glomeruli shared the same ultrastructural pattern. Moreover the
ultrastructural features of both circulating cryoglobulins and glomerular deposits
could vary according to the different heavy chain classes of immunoglobulins
(Cordonnier et al, 1977; Feiner and Gallo, 1977; Gallo and Feiner, 1978).
In EMC a monocytic infiltration of glomerular capillary loops was first reported
by Monga et al., (1976) and Mihatsch, ZoUinger and Imbasciati (1978). Mono-
nuclear cells were found in the majority of our renal specimens.
These cells, stuffed with numerous droplets of an homogeneous and electron-
dense material, might contribute to the occlusion of capillary loops. Similarly
several recent studies pointed out that the presence of macrophages in glomeruli
contributes significantly to the glomerular hypercellularity in experimental
glomerulonephritides (Kalowski, McKay, Howes, Csavossy, and Wolfson, 1976;
Holdsworth, Thompson, Glasgow, Dowling, and Atkins, 1978; Kondo, Shige-
matsu, and Kobayashi, 1972; Schreiner, Cotran, Pardo, and Unanue, 1978).
The significance and the role of monocytes in EMC will be discussed below.
(d) Pathogenesis of tissue damage
The demonstration of the immune complex nature of mixed cryoglobulins led
to the postulate that tissue damage and clinical manifestations were due to the
circulating IgG and IgM complexes and complement activation. Evidence for such
a mechanism was supported by several observations such as: the demonstration
of immunoglobulins and complement components in glomeruli and skin vessels
(Miescher, Paronetto, and Koffler, 1965; Douglas, Lahav, and Fudenberg, 1970;
Doe, Evans, Hobbs, and Booth, 1972; Nightingale, Solez, and Humphrey, 1977);
the presence of complement components in cryoprecipitates (Golberg and Barnett,
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1970; Cream, Howard, and Virella, 1972); the anticomplementary activity of
cryoglobulinaemic sera or isolated cryoglobulins (Balasz and Frolich, 1966;
Rother, Rother, Flad, and Miescher, 1972; Muller, Rother, and Westerhausen,
1976); hypocomplementaemia (Riethmuller, Meltzer, Franklin, and Miescher,
1966; Linscott and Kane 1975); and the production of vasculitis after the injection
of isolated cryoglobulins or rheumatoid factor in experimental animals (Baum,
Stastny, and Ziff, 1964; Herd, 1973).
We found a strong reduction of mean serum Clq, Cls and C4 levels in 30
patients. C3 levels did not differ from normal controls and mean C5, C9 and
C3PA concentrations were higher than normal (see Table 3). In 13 out of 18
patients the lowering of C4 and/or Clq, irrespective of clinical course, persisted
during the whole period of the study. This complement profile, already described
in EMC, has been related to a complement activation through classical pathway.
Further support for this contention arises by observation that the same comple-
ment abnormalities were associated with an acquired Cl Inhibitor deficiency in
several cases of EMC (Casali, Borzini, Pioltelli, Invernizzi, and Zanussi, 1978).
In all our cases C1 INH concentrations were higher than normal, thus excluding
the possibility that Clq and C4 reduction could be referred to Cl INH deficiency.
Moreover C3 and C3PA breakdown products were never detected.
On the other hand immunofluorescence studies showed C3 deposits in 27 out
of 33 biopsies, whereas Clq and/or C4 deposits were only present in 47 and 37
per cent of renal specimens respectively. The staining for complement components
was fainter than that of immunoglobulins. Now, if the complement profile was
due to complement activation, an immunofluorescence pattern similar to that
observed in diffuse proliferative lupus nephritis should be expected: i.e., bright
deposits of Clq and C4 in most cases according to the reduction of these serum
complement components (Verroust, Wilson, Cooper, Edington, and Dixon, 1974;
Wyatt, Me Adams, Forristal, Snyder, and West, 1979).
These data support our previous hypothesis that hyposynthesis rather than
activation and consumption is the cause of the marked lowering of early reacting
complement components (Tarantino et al., 1978).
Lastly two main immunofluorescence patterns were recognized: (1) deposits
along glomerular basement membranes, and (2) intraluminal thrombi with scanty,
if any, parietal deposits. On electron microscopy the intraluminal thrombi were
constituted by crystalloid material in the lumina of capillary loops as well as in
other kidney vessels. These findings suggest the possibility that physicochemical
rather than immunological mechanisms may be involved in the trapping of
protein aggregates by the kidney.
Though the mechanisms for the in vivo cryoprecipitation has not been yet
elucidated, several factors have been proposed (Grey and Kohler, 1973; Abraham,
Podel, Wistor, Johnston, and Welch, 1979). Amongst them, cooling seems
occasionally to induce vasculitis manifesting as purpura or urticaria (Wiltink,
Esseveld, Gerbrandy, and Van Eijk, 1973); however clinical manifestations were
seldom related to the cold exposure (Brouet, Clauvel, Danon, Klein, and Seligman,
1974). At any rate, if glomerular thrombi form after a cold challenge on the
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extremities, it is unlikely that the protein aggregates reach the kidney or deeper
tissues in spite of the higher central blood temperature.
Protein concentration seems to be one of the most important variables which
affects cold precipitation. Indeed, the higher the protein concentration, the higher
the temperature at which cryoprecipitation may occur (Lockwood, 1979). Since
a pronounced increase in serum viscosity after concentration of plasma in
glomeruli takes place, physicochemical characteristics of cryoglobulins could
account for the presence of intraluminal thrombi in kidney vessels.
In this series a monocytic infiltration was detected in the majority of renal
specimens studied by electron microscopy. Although the role of these infiltrating
cells is unknown, one might speculate that they have a scavenger function akin to
that occurring in wound healing. Such a possibility is confirmed by the observation
of homogeneous electron dense droplets in monocytes, similar to macrophages
actively phagocyting the debris. In addition these cells have been reported to
phagocytose mesangial deposits in experimental immune complex nephritis
(Striker, Mannik, and Tang, 1979). Alternatively, monocytes may represent
another mediator of tissue damage. In fact, Cardella, Davies, and Allison (1974)
stressed that the release of lysosomal enzymes by activated macrophages causes
effects similar to the neutrophil mediated tissue damage. Moreover macrophage
infiltration may suggest a participation of cell-mediated immune mechanisms other
than classic immune complex deposition in the pathogenesis of the glomerular
lesions and widespread vasculitis. This would be consistent with the presence of
monocytes in and around the vessels in several idiopathic vasculitis (Waksman,
1971; Soter, 1976). A more intriguing possibility is that the accumulation of
mononuclear cells may contribute per se to the proliferation of glomerular cells;
indeed factors secreted by macrophages induce proliferation of cultured fibroblasts
and vascular endothelium (Leibowich and Ross, 1976; Polverini, Cotran,
Gimbrone and Unanue, 1977). The almost constant presence of proliferative
lesions in cryoglobulinaemic nephritis might be related to monocytes.
Whatever the role of monocytes, the simultaneous presence of intraluminal
thrombi and monocytes suggests that tissue damage may be initiated by circulating
IgM-IgG complexes. Subsequently their deposition in glomeruli stimulates the
arrival of mononuclear cells. During the phagocytosis of the cryoproteins the
release of some enzymes by macrophages as well as the raised protein concen-
tration and/or other haemodynamic factors in the kidney cortex might trigger a
massive cryoprecipitation.
(e) Prognosis
The follow-up of 39 patients extended from three to 146 months (mean 53-8).
Ten patients showed a longstanding remission of renal manifestations and 16
patients maintained normal renal function in spite of persistent urinary abnor-
malities. Conversely 13 patients experienced several syndromes as acute renal
failure, nephrotic and acute nephritic syndrome, followed sometimes by complete
remission. Some patients developed more than one of these syndromes during the
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period of observation. A similar propensity to acute exacerbations and apparent
spontaneous remission of renal disease characterizes cryoglobulinaemic nephritis.
In previous reports progressive scarring of glomeruli was found in serial
biopsies (Morel-Maroger et al, 1974) and a high mortality rate has been observed
in patients with acute nephritic episodes. Therefore an ominous prognosis has
been related to the appearance of renal impairment in EMC. Despite these earlier
experiences, some other reports emphasized that progressive renal failure may be
reversible (Verroust et al., 1971; Morel-Maroger and Verroust, 1974; Ponticelli,
Imbasciati, Tarantino, and Pietrogrande, 1977). Amongst 50 patients, reviewed
in the literature, with histologically proven diffuse glomerulonephritis, only two
underwent regular dialysis (Bartlow et al., 1975; Cream, 1976), showing, thus
a better prognosis than that of primary or systemic proliferative glomerulo-
nephritides such as in systemic lupus erythematosus (Cameron, Glasgow, Ogg,
and White, 1970; Habib, Kleinknecht, Gubler, and Levy, 1973; Hecht, Siegel,
Adler, Kashgarian, and Hayslett, 1976; Baldwin, Gluck, Lowenstein and Gallo,
1977).
In the present series 12 patients died. Renal failure was directly responsible
for death only in one patient {Case 2 7). Furthermore, recovery of kidney function
was achieved in nine out of 13 patients with acute renal failure or acute nephritic
syndrome. Chronic renal failure developed in three patients but only one required
regular dialysis. The cumulative survival rate in our patients, all of them showing
kidney disease, was 75 per cent at 10 years. No difference was detectable between
patients with or without renal manifestations at the onset of the disease.
Most of our patients died of cardiovascular disease. This may be accounted
for by the high incidence of arterial hypertension which proved to be refractory to
treatment in about one fifth of our patients. Similarly most of the patients reported
in the literature with an unfavourable outcome had severe hypertension; although
the prognostic role of hypertension has never been stressed before, we think that
the prognosis in EMC is determined more by the development of severe hyper-
tension, than kidney damage.
( / ) Treatment
Since the course of EMC often extends over several years with unpredictable
remissions and exacerbations, therapy remains a puzzling problem. Different
approaches have been used such as corticosteroids (Klein et al., 1968; Skrifvars
et al., 1973; Reza, Roth, Pops, and Goldberg, 1974; Gamble and Ruggles, 1978),
cytotoxic drugs (Rigo, Leval-Rutten, and Salmon, 1974), penicillamine (Goldberg
and Barnett, 1970), heparin (Martinez and Kohler, 1971), splenectomy (Mathison,
Condemi, Leddy, Callerame, Panner, and Vaughan, 1971), plasmapheresis (Clark
and Long, 1979), or a combination of these measures (Golde and Epstein, 1968;
Zlotnick et al., 1972; Slatopolski, 1976; Ristow, Griner, Abraham, and Shoulson,
1976). The value of these methods of treatment is difficult to assess since a
controlled study is lacking; however the clinical impression is that they are not
effective.
Favourable experience using pulses of methylprednisolone has been recently
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described in immune complex glomerular diseases (Cathcart, Scheinberg, Idelson,
and Couser, 1976; Levinski, Cameron, and Soothill, 1977; Lockwood, Rees,
Pinching, Pussel, Sweny, and Peters, 1977; Ponticelli, Tarantino, Pioltelli, and
Invernizzi, 1977; Bolton and Couser, 1979) and in one case of monoclonal
cryoglobulinaemia with acute renal failure (Ponticelli et al., 1977a) suggesting
that intravenous high doses of steroids might be useful in EMC too. In addition to
combined immunosuppressive agents and steroids, we repeatedly used intravenous
methylprednisolone pulses in 15 patients with severe renal and/or extrarenal
symptoms. In 11 of them we added antiplatelet drugs and heparin on the assump-
tion that cryoglobulins may activate platelets (Cortellaro, Lambertenghi-Deliliers,
Cofrancesco, Pogliani, Pozzoli, Imbasciati, and Praga, 1975). A dramatic
remission of extrarenal symptoms such as fever, purpura, arthralgias and
abdominal pain was obtained soon after the methylprednisolone infusion. Also
in eight out of 15 patients renal manifestations (proteinuria, haematuria, and
plasma creatinine) showed some improvement. The mortality rate was lower—
even if non-significantly—in patients treated with methyl prednisolone.
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